Antibiotic resistance of S. pneumoniae and H. influnenzae strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study: National project supported by a grant from GlaxoSmithKline Company;Spectrul de rezistenţǎ la antibiotice a tulpinilor de S. pneumoniae i H. influenzae izolate de la pacienţi cu infecţii comunitare de tract respirator: Studiul multicentric, multidisciplinar BACTRO

Pneumologia

Volumn 60, Issue 1, 2011, Pages 30-35

  Tudose, Cornelia ^a   Bumbǎ, Dragoş ^a   Bogdan, Miron ^a  

^a Institut de Pneumologie Marius Nasta   (Romania)

Author keywords

Antibiotic resistance; Respiratory infections

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; MACROLIDE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; CHILD; CLINICAL TRIAL; COMMUNICABLE DISEASE; DRUG EFFECT; FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; INTERDISCIPLINARY COMMUNICATION; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; PENICILLIN RESISTANCE; PRESCHOOL CHILD; PREVALENCE; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; ROMANIA; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MICROBIAL; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; INFANT, NEWBORN; INTERDISCIPLINARY COMMUNICATION; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMONIA, BACTERIAL; PREVALENCE; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; ROMANIA; STREPTOCOCCUS PNEUMONIAE;

EID: 79958292416     PISSN: 20672993     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bochud PY, Moser F, Erard P et al. Community acquired pneumonia. A prospective outpatient study. Medicine (Baltimore) 2001; 80: 75-87. (Pubitemid 32285205)
2. Almirall J, Bolibar I, Vidal J et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000; 15: 757-763. (Pubitemid 30196306)
3. Roson B, Carratala J, Dorca J et al. Etiology, reasons for hospitalization, risk classes, and outcomes of communityacquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001; 33: 158-165. (Pubitemid 32643329)
4. De Roux A, Ewig S, Garc?a E et al. Mixed community-acquired pneumonia in hospitalised patients Eur Respir J 2006; 27: 795-800 (Pubitemid 44914205)
5. Etiologic Diagnosis of Adult Bacterial Pneumonia by Culture and PCR Applied to Respiratory Tract Samples. Journal of Clinical Microbiology, Feb. 2006, p. 643-645
6. Sethi S, Evans N, Grant BJ et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl Jmed 2002; 347:465-471. (Pubitemid 34879333)
7. Perez-Trallero E, Garcia-de-la-Fuente C, Garcia-Rey C et al. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother 2005; 49:1965-72. (Pubitemid 40631613)
8. Metlay JP. Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia. Infect Dis Clin North Am 2004; 18:777-90. (Pubitemid 39536008)
9. Bauer T, Ewig S, Marcos MA et al. Streptococcus pneumoniae in community-acquired pneumonia: how important is drug resistance? Med Clin North Am 2001; 85:1367-79. (Pubitemid 32980008)
10. Turnidge J, David L. Paterson. Setting and Revising Antibacterial Susceptibility Breakpoints, Clinical Microbiology Reviews, July 2007, p. 391-408 (Pubitemid 47175010)
11. Turnidge J, Bordash G. Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing. Antimicrob. Agents Chemother, 2007, 51:2483-2488. (Pubitemid 47047327)
12. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20 Wayne, PA: Clinical and Laboratory Standards Institute ; 2010.
13. http://www.eucast.org
14. Dorob O, Moisoiu A, Tlpan D. Incidence and resistance patterns of pathogens from lower respiratory tract infections (LRTI). Pneumologia, 2007 Jan-Mar; 56(1): 7-15
15. Jacobs M, Felmingham D, Appelbaum P and the Alexander Project Group; The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents; Journal of Antimicrobial Chemotherapy (2003) 52, 229-246 (Pubitemid 36986885)
16. Musher D, Dowell M, Shortridge Vet al. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N Engl J Med 2002; 346:630-1.
17. Hoban D, Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of H. influenzae and M. catarhallis from community-acquired respiratory tract infections. Journal of Antimicrobial Chemotherapy (2002) 50, Suppl. S1, 49-59.
18. Morrissey I, Maher K, Williams L et al.BSAC Working Parties on Resistance Surveillance. Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007. J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii97-103.
19. Garcia-Cobos S, Campos J, Lazaro E et al. Ampicillin-resistant non-betalactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother. 2007 Jul;51(7):2564-73. Epub 2007 Apr 30. (Pubitemid 47047338)
20. Morrisey I, Robbins M, Viljoen L et al. Antimicrobial susceptibility of communityacquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods. Journal of Antimicrobial Chemotherapy (2005) 55, 200-208. (Pubitemid 40331146)